Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Use of a mechanical thrombectomy device to treat early hepatic artery thrombosis after orthotopic liver transplant.

Meek JC, McDougal JS, Borja-Cacho D, Meek ME.

Radiol Case Rep. 2017 Dec 28;13(2):522-526. doi: 10.1016/j.radcr.2017.12.007. eCollection 2018 Apr.

2.

Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China.

Hammett TM, Des Jarlais DC, Kling R, Kieu BT, McNicholl JM, Wasinrapee P, McDougal JS, Liu W, Chen Y, Meng D, Doan N, Tho HN, Quyen NH, Tren VH.

PLoS One. 2012;7(8):e43141. doi: 10.1371/journal.pone.0043141. Epub 2012 Aug 27.

3.

Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.

Masciotra S, McDougal JS, Feldman J, Sprinkle P, Wesolowski L, Owen SM.

J Clin Virol. 2011 Dec;52 Suppl 1:S17-22. doi: 10.1016/j.jcv.2011.09.011. Epub 2011 Oct 5.

PMID:
21981983
4.

Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence.

McNicholl JM, McDougal JS, Wasinrapee P, Branson BM, Martin M, Tappero JW, Mock PA, Green TA, Hu DJ, Parekh B; Thai-U.S. BED Assay Validation Working Group.

PLoS One. 2011 Mar 4;6(3):e14748. doi: 10.1371/journal.pone.0014748.

5.

Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.

Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, Constantine N, Overbaugh J, McDougal JS.

AIDS Res Hum Retroviruses. 2011 Mar;27(3):265-73. doi: 10.1089/aid.2010.0159. Epub 2010 Oct 18.

PMID:
20954834
6.

Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa.

Kim AA, McDougal JS, Hargrove J, Rehle T, Pillay-Van Wyk V, Puren A, Ekra A, Borget-Alloue MY, Adje-Toure C, Abdullahi AS, Odawo L, Marum L, Parekh BS.

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1051-61. doi: 10.1089/aid.2009.0218. Epub 2010 Sep 19.

PMID:
20849299
7.

BED estimates of HIV incidence must be adjusted.

McDougal JS.

AIDS. 2009 Sep 24;23(15):2064-5; author reply 2066-8. doi: 10.1097/QAD.0b013e32832eff6e. No abstract available.

PMID:
19755866
8.

Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.

Owen SM, Yang C, Spira T, Ou CY, Pau CP, Parekh BS, Candal D, Kuehl D, Kennedy MS, Rudolph D, Luo W, Delatorre N, Masciotra S, Kalish ML, Cowart F, Barnett T, Lal R, McDougal JS.

J Clin Microbiol. 2008 May;46(5):1588-95. doi: 10.1128/JCM.02196-07. Epub 2008 Mar 5.

9.

Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, Chidawanyika H, Moulton LH, Ward B, Nathoo K, Iliff PJ, Kopp E.

AIDS. 2008 Feb 19;22(4):511-8. doi: 10.1097/QAD.0b013e3282f2a960.

PMID:
18301064
10.

Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2.

Pau CP, Luo W, McDougal JS.

J Immunol Methods. 2007 Jan 10;318(1-2):59-64. Epub 2006 Nov 27.

PMID:
17169369
11.

Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.

McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):945-52.

PMID:
17067263
12.

Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ.

AIDS. 2005 May;19 Suppl 2:S25-30. Review.

PMID:
15930838
13.

Application of laboratory methods for estimation of HIV-1 incidence.

Parekh BS, McDougal JS.

Indian J Med Res. 2005 Apr;121(4):510-8. Review.

PMID:
15817960
14.
15.

Performance of the OraQuick and Hema-Strip rapid HIV antibody detection assays by non-laboratorians.

Granade TC, Parekh BS, Phillips SK, McDougal JS.

J Clin Virol. 2004 Jul;30(3):229-32.

PMID:
15135740
16.

Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia.

Yang C, Li M, Cowart F, Rudolph D, Parekh B, McDougal JS, Lal RB.

J Clin Virol. 2004 Jul;30(3):224-8.

PMID:
15135739
17.

Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.

Lindegren ML, Kobrynski L, Rasmussen SA, Moore CA, Grosse SD, Vanderford ML, Spira TJ, McDougal JS, Vogt RF Jr, Hannon WH, Kalman LV, Chen B, Mattson M, Baker TG, Khoury M.

MMWR Recomm Rep. 2004 Jan 16;53(RR-1):1-29. Review.

18.

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.

Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan EK, Gordon TP, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wilson M, Byrd MG, Slivka L, Koziol JA.

J Rheumatol. 2003 Nov;30(11):2374-81.

PMID:
14677180
19.

HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.

Hu DJ, Vanichseni S, Mock PA, Young NL, Dobbs T, Byers RH Jr, Choopanya K, van Griensven F, Kitayaporn D, McDougal JS, Tappero JW, Mastro TD, Parekh BS.

AIDS Res Hum Retroviruses. 2003 Sep;19(9):727-30.

PMID:
14585202
20.

Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients.

Ackers ML, Parekh B, Evans TG, Berman P, Phillips S, Allen M, McDougal JS.

J Infect Dis. 2003 Mar 15;187(6):879-86. Epub 2003 Feb 27.

PMID:
12660933
22.

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):295-307.

PMID:
11860677
23.

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.

Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wiik A, Wilson M, Koziol JA.

J Rheumatol. 2002 Jan;29(1):68-74.

PMID:
11824974
24.

CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.

Nicholson JK, Browning SW, Hengel RL, Lew E, Gallagher LE, Rimland D, McDougal JS.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):105-15.

PMID:
11404531
26.

Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.

Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS.

AIDS Res Hum Retroviruses. 2001 Jan 20;17(2):137-46.

PMID:
11177393
27.

Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.

Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS.

J Immunol. 1999 Sep 15;163(6):3539-48.

28.

Lymphocyte kinetics and precursor frequency-dependent recovery of CD4(+)CD45RA(+)CD62L(+) naive T cells following triple-drug therapy for HIV type 1 infection.

Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS.

AIDS Res Hum Retroviruses. 1999 Mar 20;15(5):435-43.

PMID:
10195753
29.

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.

Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Rothfield NF, Smeenk R, Takasaki Y, van Venrooij WJ, Wiik A, Wilson M, Koziol JA.

Arthritis Rheum. 1999 Mar;42(3):455-64.

30.

Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.

Hengel RL, Kennedy MS, Steketee RW, Thea DM, Abrams EJ, Lambert G, McDougal JS.

AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):475-81.

PMID:
9566549
31.

Range of antinuclear antibodies in "healthy" individuals.

Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA.

Arthritis Rheum. 1997 Sep;40(9):1601-11.

PMID:
9324014
32.
33.

Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates.

Allaway GP, Davis-Bruno KL, Beaudry GA, Garcia EB, Wong EL, Ryder AM, Hasel KW, Gauduin MC, Koup RA, McDougal JS, et al.

AIDS Res Hum Retroviruses. 1995 May;11(5):533-9.

PMID:
7576908
34.
35.

HIV-1 and bleach.

Garza BW, Drotman DP, Martin LS, McDougal JS, Bond WW, Jones TS.

J Acquir Immune Defic Syndr. 1994 Feb;7(2):169-70. No abstract available.

PMID:
8301527
36.

The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.

Rice WG, Schaeffer CA, Graham L, Bu M, McDougal JS, Orloff SL, Villinger F, Young M, Oroszlan S, Fesen MR, et al.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9721-4.

37.

Cross-reactivity of 75 monoclonal antibodies to human immunoglobulin with sera of non-human primates.

Black CM, McDougal JS, Holman RC, Evatt BL, Reimer CB.

Immunol Lett. 1993 Aug;37(2-3):207-13.

PMID:
8258461
38.

Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry.

Nicholson JK, Browning SW, Orloff SL, McDougal JS.

J Immunol Methods. 1993 Apr 2;160(2):215-8.

PMID:
8459108
39.
41.

Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.

Rice WG, Schaeffer CA, Harten B, Villinger F, South TL, Summers MF, Henderson LE, Bess JW Jr, Arthur LO, McDougal JS, et al.

Nature. 1993 Feb 4;361(6411):473-5.

PMID:
8429889
42.

The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals.

Nicholson JK, Holman RC, Jones BM, McDougal JS, Sprauer MA, Markowitz LE.

J Acquir Immune Defic Syndr. 1992;5(5):528-9. No abstract available.

PMID:
1560351
43.

Analysis of synergism/antagonism between HIV-1 antibody-positive human sera and soluble CD4 in blocking HIV-1 binding and infectivity.

Kennedy MS, Orloff S, Ibegbu CC, Odell CD, Maddon PJ, McDougal JS.

AIDS Res Hum Retroviruses. 1991 Dec;7(12):975-81.

PMID:
1687500
44.

CD4-gp120 interactions.

McDougal JS, Klatzmann DR, Maddon PJ.

Curr Opin Immunol. 1991 Aug;3(4):552-8. Review.

PMID:
1721822
45.

HIV-1 binding to CD4 T cells does not induce a Ca2+ influx or lead to activation of protein kinases.

Orloff GM, Kennedy MS, Dawson C, McDougal JS.

AIDS Res Hum Retroviruses. 1991 Jul;7(7):587-93.

PMID:
1685089
46.

Infection of human monocytes with HIV-1Ba-L. Effect on accessory cell function for T-cell proliferation in vitro.

Melendez-Guerrero LM, Nicholson JK, McDougal JS.

AIDS Res Hum Retroviruses. 1991 May;7(5):465-74.

PMID:
1873081
47.
48.
49.

Human markers for IgG2 and IgG4 appear to be on the same molecule in the chimpanzee.

Black CM, McDougal JS, Evatt BL, Reimer CB.

Immunology. 1991 Jan;72(1):94-8.

50.

Role of CD4 in the penetration of cells by HIV.

McDougal JS, Maddon PJ, Orloff G, Clapham PR, Dalgleish AG, Jamal S, Weiss RA, Axel RA.

Adv Exp Med Biol. 1991;300:145-54; discussion 155-8. No abstract available.

PMID:
1685856

Supplemental Content

Loading ...
Support Center